Meningitis Epidemic Meningococcal

Epidemic meningococcal meningitis is an acute infectious disease caused by meningococci and characterized by inflammation of the membranes of the brain and spinal cord.

The disease is transmitted by airborne droplets and has a tendency to spread epidemically. The source of infection is a sick person or carrier. Meningococci are localized in the nasopharynx and when sneezing or coughing they spread with droplets of saliva and mucus.

The incubation period ranges from 2 to 10 days. The disease begins acutely, with a rise in temperature to 38-40 degrees, chills, headache, nausea, and vomiting. A characteristic symptom is a stiff neck.

Complications may include swelling of the brain, convulsions, and disturbances of consciousness. Mortality in epidemic meningitis reaches 10-15%.

For diagnosis, blood tests, cerebrospinal fluid, PCR, and bacteriological examination are used. Treatment is carried out with antibiotics, according to indications - detoxification and symptomatic therapy.

Prevention includes isolation of patients, emergency chemoprophylaxis of contact persons and vaccination. Timely detection of the disease and adequate therapy can prevent severe complications of epidemic meningitis.

Epidemic meningitis is a serious infectious disease that is characterized by inflammation of the membranes of the brain and spinal cord. The causative agent of the disease is menigococcus, a bacterium that is transmitted from person to person by coughing, sneezing, talking, etc.

Symptoms of meningitis may include fever, headache, vomiting, confusion and a stiff neck. In rare cases, meningitis can lead to the death of the patient.

Treatment of epidemiological meningitis consists of antibiotics as well as supportive care. Immunotherapy and immunoglobulin are used to improve the immune response.